Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Molecular imaging of the dopaminergic system and its association with human cognitive function.

Cropley VL, Fujita M, Innis RB, Nathan PJ.

Biol Psychiatry. 2006 May 15;59(10):898-907. Review.

PMID:
16682268
2.

Imaging in Parkinson's disease: the role of monoamines in behavior.

Brooks DJ, Piccini P.

Biol Psychiatry. 2006 May 15;59(10):908-18. Epub 2006 Apr 11. Review.

PMID:
16581032
3.

Dopamine and the regulation of cognition and attention.

Nieoullon A.

Prog Neurobiol. 2002 May;67(1):53-83. Review.

PMID:
12126656
4.

Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.

Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB.

Psychiatry Res. 2008 Jul 15;163(2):171-82. doi: 10.1016/j.pscychresns.2007.11.003. Epub 2008 May 27.

PMID:
18504119
5.

Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease.

Polito C, Berti V, Ramat S, Vanzi E, De Cristofaro MT, Pellicanò G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A.

Neurobiol Aging. 2012 Jan;33(1):206.e29-39. doi: 10.1016/j.neurobiolaging.2010.09.004. Epub 2010 Oct 20.

PMID:
20961661
6.

The role of dopamine for the pathophysiology of schizophrenia.

Meisenzahl EM, Schmitt GJ, Scheuerecker J, Möller HJ.

Int Rev Psychiatry. 2007 Aug;19(4):337-45. Review.

PMID:
17671867
7.

Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.

Kaasinen V, Rinne JO.

Neurosci Biobehav Rev. 2002 Nov;26(7):785-93. Review.

PMID:
12470690
8.

Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.

Kugaya A, Fujita M, Innis RB.

Ann Nucl Med. 2000 Feb;14(1):1-9. Review.

PMID:
10770574
9.

Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.

Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ.

Brain. 2008 May;131(Pt 5):1294-302. doi: 10.1093/brain/awn054. Epub 2008 Mar 24.

PMID:
18362097
10.

The role of extrastriatal dopamine D2 receptors in schizophrenia.

Takahashi H, Higuchi M, Suhara T.

Biol Psychiatry. 2006 May 15;59(10):919-28. Review.

PMID:
16682269
11.

Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes.

Bäckman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L.

Brain. 1997 Dec;120 ( Pt 12):2207-17.

PMID:
9448576
12.

Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders.

Verhoeff NP.

Psychopharmacology (Berl). 1999 Dec;147(3):217-49. Review.

PMID:
10639681
13.

Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).

Nobili F, Morbelli S, Arnaldi D, Ferrara M, Campus C, Brugnolo A, Mazzei D, Mehrdad N, Sambuceti G, Rodriguez G.

J Neurol Sci. 2011 Nov 15;310(1-2):31-5. doi: 10.1016/j.jns.2011.06.053. Epub 2011 Jul 16. Review.

PMID:
21762928
14.

Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.

Erritzoe D, Talbot P, Frankle WG, Abi-Dargham A.

Neuroimaging Clin N Am. 2003 Nov;13(4):817-32. Review.

PMID:
15024964
15.

Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.

Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O.

Arch Neurol. 2000 Apr;57(4):470-5.

PMID:
10768619
16.

Metabolic brain networks associated with cognitive function in Parkinson's disease.

Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D.

Neuroimage. 2007 Jan 15;34(2):714-23. Epub 2006 Nov 17.

17.

Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

Laruelle M.

Q J Nucl Med. 1998 Sep;42(3):211-21. Review.

PMID:
9796369
18.
19.

A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition.

Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA.

Neuroimage. 2005 Oct 15;28(1):216-26. Epub 2005 Jun 24.

PMID:
15979345
20.

Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.

Brücke T, Wenger S, Podreka I, Asenbaum S.

Wien Klin Wochenschr. 1991;103(21):639-46. Review.

PMID:
1771898

Supplemental Content

Support Center